Positron Emission Tomography/Computed Tomography for Gynecologic Malignancies.

IMPORTANCE

Positron emission tomography/Computed tomography(PET/CT) is widely used for gynecologic cancers.

OBJECTIVE

To determine when PET/CT should be used for gynecologic cancers.

EVIDENCE ACQUISITION: PubMed was reviewed for articles on PET/CT of all gynecologic cancers. National Comprehensive Cancer Network, Society of Gynecologic Oncology, and American College of Radiology guidelines were reviewed.

RESULTS

Whole-body PET/CT is useful for (1) initial staging of cervical and endometrial cancer, posttherapy assessment, radiation therapy planning, and posttreatment surveillance of cervical cancer, and (2) assessment of recurrence of cervical, endometrial, or ovarian cancer in the presence of symptoms. It is also useful for staging and recurrence of uterine sarcomas, and for staging of vulvar and vaginal cancer.

CONCLUSIONS

Positron emission tomography/Computed tomography is clinically valuable for a variety of gynecologic cancers.

RELEVANCE: PET/CT plays an important role in detection of initial disease and recurrence of gynecologic malignancies.